Population Pharmacokinetic Analysis of Linezolid in Low Body Weight Patients with Renal Dysfunction
- 5 August 2013
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 53 (9), 967-973
- https://doi.org/10.1002/jcph.133
Abstract
Linezolid has antibacterial activity against aerobic Gram‐positive cocci, including methicillin‐resistant Staphylococcus aureus (MRSA). Adjustment of the dose of linezolid has been proposed to be unnecessary in patients with reduced renal function. However, platelet counts and hemoglobin levels were shown to be significantly lower in such patients than in patients with normal renal function. The population pharmacokinetic (PPK) of linezolid was investigated in MRSA infected patients with renal dysfunction. Linezolid concentrations in serum were measured by high‐performance liquid chromatography. PPK analysis was performed in the nonlinear mixed effects model (NONMEM) computer program. In the final PPK model, total body weight (TBW), estimated glomerular filtration rate (eGFR), hemoglobin (HB), and alanine amino transferase (ALT) were influential covariates on total body clearance (CL), and the volume of distribution (Vd) was affected by TBW, which was expressed as CL (L/h) = 0.00327 × TBW × eGFR0.428 × HB0.502 × 0.283 (ALT ≥ 100 IU/L) and CL (L/h) = 0.00327 × TBW × eGFR0.428 × HB0.502 (ALT < 100 IU/L), Vd (L) = 1.310 × TBW. The PPK parameters of linezolid obtained here are useful for the optimal use of linezolid with similar patient population characteristics.Keywords
This publication has 20 references indexed in Scilit:
- Influence of Linezolid Clearance on the Induction of Thrombocytopenia and Reduction of HemoglobinThe American Journal of the Medical Sciences, 2011
- Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese PatientsAntimicrobial Agents and Chemotherapy, 2011
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiencyInternational Journal of Antimicrobial Agents, 2006
- Pharmacokinetics of Unbound Linezolid in Plasma and Tissue Interstitium of Critically Ill Patients after Multiple Dosing Using MicrodialysisAntimicrobial Agents and Chemotherapy, 2006
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Pharmacokinetics of Linezolid in Subjects with Renal DysfunctionAntimicrobial Agents and Chemotherapy, 2003
- Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use ProgramAntimicrobial Agents and Chemotherapy, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- Thrombocytopenia Associated with Linezolid TherapyClinical Infectious Diseases, 2002